PofoliaPofolia ile paylaşıldı

European Archives of Oto-Rhino-Laryngology· 2026Q1

Baş ve boyun skuamöz hücreli karsinomunda kantitatif patolojik lenf nodu parametreleri: klinik olarak ilgili alt gruplarda tamamlayıcı prognostik değerin kapsamlı bir analizi

Quantitative pathological lymph node parameters in head and neck squamous cell carcinoma: a comprehensive analysis of complementary prognostic value in clinically relevant subgroups

Cornelius H. L. Kürten, Valentin Funk, Sarah Theurer, Marc Ingenwerth ve diğerleri

Kısa özet

Lenf nodu verimi (LNY), lenf nodu oranı (LNR) ve ağırlıklı lenf nodu oranı (WLNR), HPV ile ilişkisiz baş ve boyun skuamöz hücreli karsinomunda (HNSCC) bağımsız olarak sağkalımı öngörmektedir; LNY ayrıca nod negatif hastalarda ve adjuvan tedavi almayanlarda WLNR prognostiktir.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Ana noktalar

  • LNY, LNR ve WLNR, HPV ile ilişkisiz HNSCC'de genel sağkalımla bağımsız olarak ilişkilidir (HR'ler 1.58-2.30).
  • WLNR en yüksek ayrımcı performansı göstermektedir (C-indeksi 0.61).
  • Prognostik sinyal esas olarak ipsilateral boyun diseksiyonundan kaynaklanmaktadır.
  • LNY nod negatif hastalarda (HR 1.88) ve WLNR adjuvan tedavi almayan hastalarda (HR 2.31) prognostiktir.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Özet (abstract)

Abstract Purpose Quantitative pathological lymph node parameters (qpLNP), i.e. lymph node yield (LNY), lymph node ratio (LNR), and weighted lymph node ratio (WLNR), are potential prognostic markers in head and neck squamous cell carcinoma (HNSCC). Incorporation into post-operative staging may help to direct more precise adjuvant treatment regimens. Available data warrant more detailed subgroup analyses, we therefore evaluated their prognostic value with particular attention to neck dissection laterality, pN0 disease, and patients without recommendation for adjuvant therapy. Methods We performed a retrospective analysis of 410 surgically treated HNSCC patients from a single tertiary center (2010–2020). Data-derived cutoffs were determined by recursive partitioning. Overall survival was analyzed using Kaplan-Meier estimates, log-rank tests, and multivariable Cox regression. 67 patients with HPV-associated oropharyngeal carcinoma were analyzed separately. Results In 343 patients with HPV-unrelated HNSCC, LNY, LNR, and WLNR were independently associated with overall survival on multivariable analysis (LNY: HR 1.58, p =0.012; LNR: HR 1.77, p =0.026; WLNR: HR 2.30, p <0.001). Discriminative performance increased from LNY (C-index 0.55) to LNR (0.59) to WLNR (0.61). Prognostic signal was primarily driven by the ipsilateral and not the contralateral neck. LNY (HR 1.92, p =0.044) and WLNR (HR 2.31, p =0.038) showed prognostic value in patients without adjuvant therapy, and LNY remained independently prognostic in node-negative patients on multivariable analysis (HR 1.88, p =0.027). Site-specific analyses in patients with HPV-unrelated oropharyngeal carcinoma and oral cavity carcinoma treated with bilateral neck dissection confirmed independent prognostic value for LNY and WLNR in both subgroups. In HPV-associated oropharyngeal carcinoma, qpLNP held no prognostic value. Here, extranodal extension was the dominant prognostic factor. Conclusion LNY, LNR, and WLNR provide complementary prognostic information in HPV-unrelated HNSCC. The validity of LNY in node-negative patients emphasizes its value as a quality control parameter for surgery while WLNR’s performance in patients without adjuvant therapy suggests additional value in patient stratification for adjuvant treatment.

Yazarların özeti; kaynağından alınmıştır. European Archives of Oto-Rhino-Laryngology, 2026 · DOI ↗

ÇıkarımlarPremium
Makaleye SorÜcretsiz hesapla

Ücretsiz hesapla devam et

Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.

Web'de ücretsiz devam et

Google ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.

Telefonda:

Alan: Kulak Burun Boğaz

OtorhinolaryngologyMedicine